Wave Life Sciences Ltd.
Clinical trials sponsored by Wave Life Sciences Ltd., explained in plain language.
-
New hope for duchenne: Long-Term safety trial of WVE-N531 underway
Disease control ENROLLING_BY_INVITATIONThis study is for people with Duchenne muscular dystrophy who have already taken the experimental drug WVE-N531 in a previous study. The goal is to check the drug's long-term safety and how well it works over time. Participants will receive the drug intravenously and undergo regu…
Phase: PHASE2 • Sponsor: Wave Life Sciences Ltd. • Aim: Disease control
Last updated May 26, 2026 12:04 UTC
-
New hope for rare lung and liver disease: experimental drug WVE-006 enters human testing
Disease control OngoingThis study tests a new drug, WVE-006, in 24 adults with a specific genetic form of alpha-1 antitrypsin deficiency (Pi*ZZ). The goal is to see if the drug is safe and can raise levels of a protective protein in the blood. Participants receive either a single dose or multiple doses…
Phase: PHASE1, PHASE2 • Sponsor: Wave Life Sciences Ltd. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC